Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-10-02
2007-10-02
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
Reexamination Certificate
active
10802280
ABSTRACT:
The invention is directed to a method of increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate by administration of a therapeutically effective amount of the drug with food. The invention also provides a kit comprising a pharmaceutical composition comprising a therapeutically effective amount of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and a pharmaceutically acceptable carrier, prescribing information, and a container, wherein the prescribing information includes advice to a patient regarding administration of the drug with food to improve bioavailability.
REFERENCES:
patent: 3576830 (1971-04-01), Fukumaru et al.
patent: 4346277 (1982-08-01), Wojtecki et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4681893 (1987-07-01), Roth
patent: 4740438 (1988-04-01), Krishnamurthy
patent: 4853319 (1989-08-01), Krishnamurthy et al.
patent: 5011930 (1991-04-01), Fujikawa et al.
patent: 5030447 (1991-07-01), Joshi et al.
patent: 5118583 (1992-06-01), Kondo et al.
patent: 5180589 (1993-01-01), Joshi et al.
patent: 5194539 (1993-03-01), Charmot et al.
patent: 5217859 (1993-06-01), Boettcher et al.
patent: 5219721 (1993-06-01), Klaus et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5273995 (1993-12-01), Roth
patent: 5350667 (1994-09-01), Singer et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5356896 (1994-10-01), Kabadi et al.
patent: 5405969 (1995-04-01), Wright et al.
patent: 5446207 (1995-08-01), Pomponi et al.
patent: 5504097 (1996-04-01), Malamas et al.
patent: 5512548 (1996-04-01), Kushwaha et al.
patent: 5519001 (1996-05-01), Kushwaha et al.
patent: 5534529 (1996-07-01), Yoshida et al.
patent: 5542974 (1996-08-01), Buding
patent: 5556888 (1996-09-01), Koda et al.
patent: 5614550 (1997-03-01), Yoshida et al.
patent: 5622985 (1997-04-01), Olukotun et al.
patent: 5654134 (1997-08-01), Morimura et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 5698564 (1997-12-01), Katsuyama et al.
patent: 5776951 (1998-07-01), Arrowsmith et al.
patent: 5880095 (1999-03-01), Park et al.
patent: 5916595 (1999-06-01), Chen et al.
patent: 5925645 (1999-07-01), Schmidt et al.
patent: 5932587 (1999-08-01), Schmeck et al.
patent: 5969156 (1999-10-01), Briggs et al.
patent: RE36481 (2000-01-01), Inamine et al.
patent: RE36520 (2000-01-01), Smith et al.
patent: 6069148 (2000-05-01), Schmidt et al.
patent: 6080778 (2000-06-01), Yankner et al.
patent: 6093573 (2000-07-01), Beamer et al.
patent: 6126971 (2000-10-01), Mills et al.
patent: 6127383 (2000-10-01), Schmidt et al.
patent: 6140342 (2000-10-01), Goldstein et al.
patent: 6140343 (2000-10-01), DeNinno et al.
patent: 6147089 (2000-11-01), DeNinno et al.
patent: 6147090 (2000-11-01), DeNinno et al.
patent: 6197786 (2001-03-01), DeNinno et al.
patent: 6207671 (2001-03-01), Schmidt et al.
patent: 6242003 (2001-06-01), Kalb et al.
patent: 6313142 (2001-11-01), Damon et al.
patent: 6362198 (2002-03-01), Goldstein et al.
patent: 6395751 (2002-05-01), DeNinno et al.
patent: 6426365 (2002-07-01), Shinkai et al.
patent: 6448295 (2002-09-01), Sikorski et al.
patent: 6462091 (2002-10-01), Keller et al.
patent: 6753346 (2004-06-01), Shinkai et al.
patent: 2001/0018446 (2001-08-01), Sikorski et al.
patent: 2002/0103225 (2002-08-01), Curatolo et al.
patent: 2004/0039018 (2004-02-01), Ruggeri
patent: 2004/0053842 (2004-03-01), Nguyen et al.
patent: 2006/0014788 (2006-01-01), Gumkowski et al.
patent: 2000631 (1990-04-01), None
patent: 0 533 281 (1993-03-01), None
patent: 0 796 846 (1997-09-01), None
patent: 0 818 197 (1998-01-01), None
patent: 0 818 448 (1998-01-01), None
patent: 0 992 496 (2000-04-01), None
patent: 1 269 994 (2003-01-01), None
patent: 2127690 (1999-04-01), None
patent: 45-11132 (1970-04-01), None
patent: 47-35786 (1972-09-01), None
patent: 1-278543 (1989-11-01), None
patent: 1-321432 (1989-12-01), None
patent: 2-23338 (1990-01-01), None
patent: 3-226750 (1991-10-01), None
patent: 9-59155 (1997-03-01), None
patent: 10-287662 (1998-10-01), None
patent: WO 92/03408 (1992-03-01), None
patent: WO 92/03412 (1992-03-01), None
patent: WO 96/09406 (1996-03-01), None
patent: WO 96/30761 (1996-10-01), None
patent: WO 98/04528 (1998-02-01), None
patent: WO 98/23593 (1998-06-01), None
patent: WO 98/34920 (1998-08-01), None
patent: WO 98/35937 (1998-08-01), None
patent: WO 98/39299 (1998-09-01), None
patent: WO 99/14204 (1999-03-01), None
patent: WO 99/41237 (1999-08-01), None
patent: WO 99/50454 (1999-10-01), None
patent: WO 98/04528 (1999-11-01), None
patent: WO 00/17164 (2000-03-01), None
patent: WO 00/18721 (2000-04-01), None
patent: WO 00/18723 (2000-04-01), None
patent: WO 00/18724 (2000-04-01), None
patent: WO 00/38721 (2000-07-01), None
patent: WO 00/38722 (2000-07-01), None
patent: WO 00/38723 (2000-07-01), None
patent: WO 00/38724 (2000-07-01), None
patent: WO 00/38725 (2000-07-01), None
patent: WO 00/38726 (2000-07-01), None
patent: WO 00/53792 (2000-09-01), None
patent: WO 01/18250 (2001-03-01), None
patent: WO 01/40190 (2001-06-01), None
patent: WO 01/56579 (2001-08-01), None
patent: WO 02/11710 (2002-02-01), None
patent: WO 02/11710 (2002-05-01), None
patent: WO 01/18250 (2002-07-01), None
patent: WO 02/059077 (2002-08-01), None
patent: WO 03/000235 (2003-01-01), None
patent: WO 03/000295 (2003-01-01), None
patent: WO 03/063832 (2003-08-01), None
patent: WO 03/000295 (2004-05-01), None
patent: WO 2004/082593 (2004-09-01), None
patent: WO 2004/082675 (2004-09-01), None
patent: WO 2004/098583 (2004-11-01), None
Okamotot et al., Nature, vol. 406, Jul. 13, 2000, pp. 203-207.
Harrison's Principle of Internal Medicine, 13th Ed., vol. 1, published in 1994 by McGraw-Hill, Inc., pp. 1108-1116.
Jones et al., “The Curves Study”, The American Journal of Cardiology, vol. 81, Mar. 1, 1998, pp. 582-587.
The Merck Manual of Diagnosis of Therapy, 14th Ed., published 1982 by Merck, Sharp & Dohme Research Laboratories, pp. 386-389 and 550-555.
Webster's II, New Riverside University Dictionary, published in 1984 by Houghton Mifflin Co., “food” entry, p. 494.
Handbook of Pharmaceutical Excipients, published 1986 by the American Pharmaceutical Association (DC), pp. 153-162 and 289-293.
Remington's Pharmaceutical Sciences, 16thEdition, published 1980 by Mack Publishing, Inc., pp. 1715-1728 and 1855-1857.
Remington's Pharmaceutical Sciences, Osol et al., (Eds.), 16th edition, published 1980, p. 1855.
Antonova et al.,Comptes rendus de I'Academie bulgare des Sciences, 46(1), 71-74 (1993).
Connolly et al.,Biochemical and Biophysical Research Communications, 223(1), 42-47 (1996).
De Grooth et al.,XIV International Symposium on Drugs Affecting Lipid Metabolism, 47 (2001).
De Grooth et al.,Circulation, Supplement II, 104(17), 848 (2001).
Drozd,Zhumal Organicheskoi Khimii, 23(2), 355-365 (1987).
Egan et al.,Advances in Prostaglandin, Thromboxane, and Leukotriene Research, 11, 151-157 (1983).
Hori et al.,Heterocycles9(10), 1413-1418 (1978).
Huang et al.,Clinical Science, 103(6), 587-594 (2002).
Maeda et al.,Bioorganic&Medicinal Chemistry Letters, 14, 2589-2591 (2004).
Nagarajan et al.,Indian Journal of Chemistry, 12(3), 227-235 (1974).
Okamoto,Lipid, 13(1), 76-81 (2002).
Okamoto,BIO Clinica, 18(5), 429-432 (2003).
Okamoto et al.,European Journal of Pharmacology, 466(1-2), 147-154 (2003).
Shimoji et al.,Atherosclerosis, 172(2), 247-257 (2004).
Shinkai,Naibunpi, Tonyobyoka, 12(4), 364-369 (2001).
Simov et al.,Khimya Geterotsiklicheskikh Soedinenii, 9, 1192-1195 (1976).
Wakitani et al.,The Knowledge Foundation's 2ndInternational Conference on HDL Cholesterol Metabolic Pathways and Drug Development, 1 (2001).
Watts,Clinical Science, 103(6), 595-597 (2002).
WCN Working Group on Cardiovascular Research,Slide Presented at the 15thAnnual Scientific WCN Meeting, Amsterdam, The Netherlands (Dec. 2002).
Inazu et al.,Current Opinion in Investigational Drugs, 4(3): 291-297 (Mar. 1, 2003).
Wierzbicki,Expert Opinion on Emerging Drugs, 8(2): 365-376 (2003).
U.S. Appl. No. 10/802,220, filed Mar. 17, 2004, Sunami et al.
U.
Ishikawa Tomohiro
Urata Yasuo
Henley III Raymond J.
Japan Tobacco Inc.
LandOfFree
Method for increasing the bioavailability of the active form... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for increasing the bioavailability of the active form..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing the bioavailability of the active form... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898989